Search Results - Visalachy, Purushothaman

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    The Outcome of HyperCVAD Combined with Alemtuzumab for the Treatment of Aggressive T-Cell and NK-Cell Neoplasms.

    The Outcome of HyperCVAD Combined with Alemtuzumab for the Treatment of Aggressive T-Cell and NK-Cell Neoplasms. by Kuan, Jew-Win, Chang, Kian-Meng, Lau, Ngee Siang, Visalachy, Purushothaman, Tan, Sen Mui, Ong, Tee Chuan, Su, Anselm-Ting

    Published 2011
    Get full text
    Get full text
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: